BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

March 30, 1998

View Archived Issues

Preclinical and clinical results for liposomal cisplatin presented at AACR meeting

Read More

New hormonal agents discussed at cancer meeting

Read More

Protein farnesyltransferase inhibitors: preclinical studies reported at AACR

Read More

Senetek will present additional INVICORP clinical data at AUA annual meeting

Read More

Peptimmune and Peptide Therapeutics form asthma, autoimmune disease collaboration

Read More

Demeter granted U.S. patent for peptide stabilization

Read More

Canadian notice of patent allowance for Imutec's Virulizin

Read More

Detrol approved by FDA for overactive bladder

Read More

NIH offers gene expression detection technology for licensing

Read More

Another antimigraine option now available for sufferers in U.S.

Read More

U.S. patent issues for Immunex's soluble CD40 ligand

Read More

Cytokine inhibitors claimed by Novo Nordisk for diabetes and other disorders

Read More

Antimuscarinic piperidines described by Schering-Plough

Read More

Novel fusion protein with potent activity in colon cancer models reported at AACR

Read More

Adenosine derivatives for cardiovascular, lipid disorders

Read More

Extensive preclinical and clinical results presented for Bayer MMP inhibitor

Read More

New ocular agents described by Novartis

Read More

SKB develops new agents for osteoporosis and related disorders

Read More

Dendreon's dendritic cell-based immunotherapy reported at AACR

Read More

Focus on agents for estrogen deprivation continues at Lilly

Read More

KRH-594 evaluated in animal models of nephropathy, vascular hyperplasia

Read More

Karenitecins: BioNumerik's fourth-generation camptothecin derivatives

Read More

FDA approves Viagra; first oral treatment for ED on the way to market

Read More

IND filed for tissue-selective estrogen compound

Read More

XNA-2: a new treatment for skin disorders available for licensing from Xenna

Read More

Z-335 demonstrates beneficial effects in models of peripheral circulatory insufficiency

Read More

Revive: a topical treatment for androgenic alopecia available for licensing

Read More

Platelet antiaggregatory effects of liposome-encapsulated streptokinase

Read More

NC-100100 enhances myocardial infarction imaging in dogs

Read More

Excitatory amino acid receptor antagonists related to PNQX reported at ACS

Read More

U.S. universities develop new agents for PCP

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 13, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • Illustration of a motor neuron

    Keros reports beneficial effects of RKER-065 in ALS model

    BioWorld Science
    Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
  • GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D

    BioWorld Science
    Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing